NCT07193511
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07193511
Title Study of AVZO-103 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Urothelial Cancer or Other Solid Tumors (AVZO-103-1001)
Acronym AVZO-103-1001
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Avenzo Therapeutics, Inc.
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Avenzo Therapeutics Recruiting Site RECRUITING Orlando Florida 32827 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING Myrtle Beach South Carolina 29572 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING Nashville Tennessee 37203 United States Details
Avenzo Therapeutics Recruiting Site RECRUITING Austin Texas 78758 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field